5912 Venlo, nl
Solveigh Karola Mähler
+49 (2103) 29-11710
QIAGEN Unveils Revolutionary Sample Processing Platform
The QIAcube Creates New Dimension of Utility for any User Conducting Molecular Biology
QIAcube creates a new dimension of utility and opportunities to free up time, reduce costs and increase performance for customers in any laboratory in research, applied testing and molecular diagnostics. The platform will be launched for use with over 100 protocols which address almost any need in sample processing. The protocols are based on the identical QIAGEN consumable products used manually today – enabling fast and effortless migration of existing QIAGEN consumable users to the QIAcube.
The QIAcube was created to allow a new level of ease of use and is priced at a fraction of current instrumentation products. With QIAcube, QIAGEN is launching an extremely versatile, compact system in the low to medium throughput range. The QIAcube therefore expands QIAGEN’s current portfolio of automation platforms which address mid and high throughput needs as well as certain specialized applications. The QIAcube’s ease of use, throughput and application bandwidth, and value profile make it a very attractive solution for every laboratory conducting molecular biology.
Sample processing is a critical step in any sample analysis and is performed in every laboratory conducting molecular biology. Hundreds of different sample processing applications exist – depending on the sample and the target analyte (i.e., different forms of DNA, RNA, proteins, etc.). QIAGEN, the market and technology leader in sample technologies, offers by far the broadest portfolio of consumables addressing these applications. Several hundred proprietary technologies incorporated in QIAGEN consumables allow the highest levels of quality and performance. By running the same QIAGEN consumables on the QIAcube, users can free up significant time and enjoy even higher performances of already proven standards.
“QIAcube is a revolutionary new platform which marks a new era of possibilities and efficiencies in sample processing,” said Peer Schatz, Chief Executive Officer of QIAGEN. “The QIAcube allows users to enjoy an even higher level of value of our QIAGEN consumable products. It offers extensive capabilities in sample processing and is offered for use with over 100 existing standard QIAGEN protocols. The QIAcube also presents a level of user-friendliness previously unseen in our industry. These factors as well as its price which makes it accessible to any laboratory, give QIAcube the potential to become a core platform in research, applied testing and molecular diagnostics laboratories.”
- Target customers: Over 40,000 laboratories in research, applied testing and molecular diagnostics
- Applications: Low- to medium throughput (up to 12 samples per run) >100 spin-column based protocols for DNA, RNA, protein sample processing
- Developed by QIAGEN: includes proprietary technologies
- Size / weight: 65 cm (25.5 in) X 57 cm (22.4 in) X 62 cm (24.4 in) / 70.5 kg (155 lbs)
- Pictures are available at http://www.qiagen.com/goto/qiacubeimages/
QIAcube is intended for laboratory use only. No claim of representation is intended for its use to provide information for the diagnosis, prevention or treatment of a disease.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an email@example.com.